GOCOVRI
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 22 Apr 2025)
What this means for you
Registered since 08 Jan 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86698587
- Registration number
- 5649541
- Mark type
- Stylized text
- Filed
- 20 Jul 2015
- Published for opposition
- 08 Dec 2015
- Registered
- 08 Jan 2019
- Attorney of record
- Mark D. Simpson
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment of nervous system disorders
Owner
- ADAMAS PHARMA LLC, Rockville, MD, US
- ADAMAS PHARMA LLC, EMERYVILLE, CA, US
- Adamas Pharmaceuticals, Inc., Emeryville, CA, US
- Adamas Pharmaceuticals, Inc., Emeryville, CA, US
Prosecution history
- 22 Apr 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 22 Apr 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 21 Apr 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 08 Jan 2025 — TEAS SECTION 8 & 15 RECEIVED
- 18 Mar 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 18 Mar 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Mar 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 18 Mar 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 18 Mar 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 08 Jan 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 08 Jan 2019 — REGISTERED-PRINCIPAL REGISTER
- 04 Dec 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Dec 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Nov 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Nov 2018 — USE AMENDMENT FILED